Moderna ends gene editing alliance with Metagenomi
Bio Pharma Dive
MAY 2, 2024
Metagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in gene editing research in recent years.
Let's personalize your content